---
figid: PMC3342334__pone.0035885.g009
figlink: /pmc/articles/PMC3342334/figure/pone-0035885-g009/
number: Figure 9
caption: Neonatal seizures induce intense synaptic activity followed by rapid increases
  in extracellular glutamate and BDNF levels (within 1 h post-HS; ). Activation of
  glutamate receptors, including NMDA receptors (NMDARs) and Ca2+-permeable AMPA receptors
  (CP-AMPARs) , followed by opening of L-type voltage-gated Ca2+ channels (VGCCs),
  results in increased Ca2+ influx. Enhanced expression and function of BDNF activates
  the membrane-bound tyrosine kinase B receptors (TRKBRs) and, together with Ca2+
  influx, leads to the recruitment of the PI3K/PDK1/Akt and the Ras/MEK/ERK signaling
  pathways (within 1–3 h post-HS; ). Akt- and ERK-dependent inactivation of Tsc1/Tsc2
  complex results in activation of Rheb GTP-ase, and subsequent induction of mTORC1
  activity (within 12–24 h post-HS; ). In turn, the mTORC1 may inhibit 4EBP1 and enhance
  the activity of p70S6K at 12 h post-HS, leading to enhanced eIF4E and S6 signaling,
  and increased protein translation at 24 h post-HS. The negative feedback inhibition
  between p70S6K and PI3K may account for the time lag between p70S6K and S6 phosphorylation
  changes. Altered TORC1-dependent translation of synaptic plasticity proteins (such
  as PSD-95, CamKII, Arc, GluR1) , , among with other important cellular processes
  regulated by the mTORC1 kinase (autophagy, ribosomal biogenesis and cellular metabolism)
  , may lead to both short-term and long-term neuronal hyperexcitability (), enhancement
  of synaptic function (), epilepsy (), and autism-like behaviors (). Treatment with
  the mTORC1 inhibitor rapamycin immediately before and after neonatal seizures reverses
  both early and late neurological and behavioral consequences (– ).
pmcid: PMC3342334
papertitle: 'The Interaction between Early Life Epilepsy and Autistic-Like Behavioral
  Consequences: A Role for the Mammalian Target of Rapamycin (mTOR) Pathway.'
reftext: Delia M. Talos, et al. PLoS One. 2012;7(5):e35885.
pmc_ranked_result_index: '228869'
pathway_score: 0.7497811
filename: pone.0035885.g009.jpg
figtitle: 'Interaction between Early Life Epilepsy and Autistic-Like Behavioral Consequences:
  A Role for the Mammalian Target of Rapamycin (mTOR) Pathway'
year: '2012'
organisms: Homo sapiens
ndex: c065986d-df2c-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3342334__pone.0035885.g009.html
  '@type': Dataset
  description: Neonatal seizures induce intense synaptic activity followed by rapid
    increases in extracellular glutamate and BDNF levels (within 1 h post-HS; ). Activation
    of glutamate receptors, including NMDA receptors (NMDARs) and Ca2+-permeable AMPA
    receptors (CP-AMPARs) , followed by opening of L-type voltage-gated Ca2+ channels
    (VGCCs), results in increased Ca2+ influx. Enhanced expression and function of
    BDNF activates the membrane-bound tyrosine kinase B receptors (TRKBRs) and, together
    with Ca2+ influx, leads to the recruitment of the PI3K/PDK1/Akt and the Ras/MEK/ERK
    signaling pathways (within 1–3 h post-HS; ). Akt- and ERK-dependent inactivation
    of Tsc1/Tsc2 complex results in activation of Rheb GTP-ase, and subsequent induction
    of mTORC1 activity (within 12–24 h post-HS; ). In turn, the mTORC1 may inhibit
    4EBP1 and enhance the activity of p70S6K at 12 h post-HS, leading to enhanced
    eIF4E and S6 signaling, and increased protein translation at 24 h post-HS. The
    negative feedback inhibition between p70S6K and PI3K may account for the time
    lag between p70S6K and S6 phosphorylation changes. Altered TORC1-dependent translation
    of synaptic plasticity proteins (such as PSD-95, CamKII, Arc, GluR1) , , among
    with other important cellular processes regulated by the mTORC1 kinase (autophagy,
    ribosomal biogenesis and cellular metabolism) , may lead to both short-term and
    long-term neuronal hyperexcitability (), enhancement of synaptic function (),
    epilepsy (), and autism-like behaviors (). Treatment with the mTORC1 inhibitor
    rapamycin immediately before and after neonatal seizures reverses both early and
    late neurological and behavioral consequences (– ).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TSC2
  - PIK3R4
  - HRAS
  - TSC1
  - KRAS
  - ARC
  - PIK3R6
  - AKT3
  - CAMK1
  - RPS6KB1
  - PDK1
  - RHEB
  - NRAS
  - PIK3CD
  - MTOR
  - AKT1
  - AKT2
  - DLG4
  - PIK3CB
  - PIK3R3
  - PIK3CA
  - PIK3R5
  - RPS6KB2
  - MAPK1
  - GRIA1
  - PIK3CG
  - MAPK3
  - RPTOR
  - MAP2K1
  - MAP2K2
  - Glutamate
  - Rapamycin
  - Cancer
genes:
- word: (Tsc2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: (Tsc1
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Arc,
  symbol: ARC
  source: hgnc_symbol
  hgnc_symbol: ARC
  entrez: '23237'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: (PSD95,CamKI,Arc,GluR1)Days-Weeks
  symbol: CaMKI
  source: hgnc_alias_symbol
  hgnc_symbol: CAMK1
  entrez: '8536'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: Rheb
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: (PSD95,
  symbol: PSD-95
  source: hgnc_alias_symbol
  hgnc_symbol: DLG4
  entrez: '1742'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB2
  entrez: '6199'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: GluR1)
  symbol: GLUR1
  source: hgnc_prev_symbol
  hgnc_symbol: GRIA1
  entrez: '2890'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
chemicals:
- word: Glutamate
  source: MESH
  identifier: D018698
- word: Rapamycin
  source: MESH
  identifier: D020123
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
